4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-016724
Director sold 27,448 shares at an average $30.35 ($833,001)
- Director acquired 27,448 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quart Barry D Director | 2025-06-09 | Option exercise | +6,900 | $3.80 | $26,220 | 19,446 | D |
| Quart Barry D Director | 2025-06-09 | Sale | −6,900 | $30.26 | $208,794 | 12,546 | D |
| Quart Barry D Director | 2025-06-10 | Option exercise | +8,212 | $3.80 | $31,206 | 20,758 | D |
| Quart Barry D Director | 2025-06-10 | Sale | −8,212 | $30.36 | $249,316 | 12,546 | D |
| Quart Barry D Director | 2025-06-11 | Option exercise | +12,336 | $3.80 | $46,877 | 24,882 | D |
| Quart Barry D Director | 2025-06-11 | Sale | −12,336 | $30.39 | $374,891 | 12,546 | D |
| Derivatives | |||||||
| Quart Barry D Director | 2025-06-09 | Option exercise · Share Option | −6,900 | 20,548 | D | ||
| Quart Barry D Director | 2025-06-10 | Option exercise · Share Option | −8,212 | 12,336 | D | ||
| Quart Barry D Director | 2025-06-11 | Option exercise · Share Option | −12,336 | 0 | D | ||
| Open-market sales · 27,448 sh · avg $30.35 · $833,001 | |||||||
Loading xslF345X05/form4-06112025_090650.xml…